Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GUFICBIO | NSE
1.80
0.61%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
298.30
299.00
302.00
288.50
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs) generic pharmaceuticals and related services in India. It manufactures APIs and bulk drugs such as antifungals anesthetics immuno suppressants and intermediates for antifungals. The company also manufactures lyophilized injections which include antibiotic antifungal cardiac infertility antiviral and proton-pump inhibitor segments. In addition it offers spark criti care and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai India.
View LessPrice Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
21.9%1 month
40.8%3 months
36.3%6 months
33.1%50.00
-
7.99
0.63
0.30
31.17
5.96
-
1.47B
29.92B
312.71M
0.02
15.52
-2.30
4.00
19.57
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
26.40
Range1M
39.40
Range3M
53.70
Rel. volume
0.76
Price X volume
10.15M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Orchid Pharma Limited | ORCHPHARMA | Drug Manufacturers-Specialty & Generic | 566.85 | 28.86B | 0.01% | 59.92 | 11.56% |
| Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 262.68 | 27.66B | -2.27% | 17.04 | 10.32% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 169.01 | 26.50B | -3.17% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 372.35 | 26.31B | -3.39% | n/a | 10.48% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 91.42 | 23.56B | -2.15% | 12.29 | 0.42% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 41.72 | 23.05B | -2.27% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 368.55 | 23.00B | 3.38% | n/a | 2.49% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 181.1 | 22.33B | -3.22% | 69.03 | 68.84% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 477.5 | 20.69B | -4.24% | n/a | 107.90% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.34 | 19.01B | -3.48% | 42.22 | 60.54% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 31.17 | 24.85 | Expensive |
| Ent. to Revenue | 5.96 | 11.40 | Cheaper |
| PE Ratio | 50.00 | 51.36 | Par |
| Price to Book | 7.99 | 6.83 | Par |
| Dividend Yield | 0.02 | 0.52 | Poor |
| Std. Deviation (3M) | 36.34 | 42.17 | Par |
| Debt to Equity | 0.63 | 0.35 | Expensive |
| Debt to Assets | 0.30 | 0.17 | Expensive |
| Market Cap | 29.92B | 290.82B | Emerging |